Meningitis
"In vitro Antibiotic Synergy Against Flavobacterium meningosepticum: Implications for Therapeutic Options."
Published in TB and Outbreaks Week, June 29th, 1998
According to the authors' abstract of an article published in Clinical Infectious Diseases, "Flavobacterium meningosepticum is an unusual, highly resistant, Gram-negative bacillus that is associated with neonatal meningitis and nursery outbreaks of meningitis. The optimal therapy for this infection is not known. We successfully treated three neonates with intravenous vancomycin and rifampin. We determined the in vitro activity of meropenem, ciprofloxacin, vancomycin, linezolid (PNU-100766), and rifampin, alone and in combination, against four isolates of F. meningosepticum from neonates with sepsis and meningitis. MICs were determined by tube dilution, and fractional...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Drug Resistance (TB)
CDC Says Mexico Ninth in World in Resistant TB - Pathogenesis (TB)
Mouse May be Key to Understanding Mycobacterial Infection - Pediatrics
Children Have More Benign Course of Pontiac Fever - Testing (TB)
Novel Candidate Genes May Result in Better MDR-TB Treatment - Anthrax Vaccine
Most Exposed U.S. Military Personnel Will Be Immunized First - Conference Coverage (1st Annual Vaccine Research)
Effectiveness Studies Seen As Vaccine-Marketing Tool - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
